Table 3.
Antidepressants prescribed, doses and distribution by sex.
| Antidepressant | Total, n (%) N = 650 | Dose, mg/day, mean ± SD | Dose range, mg/day | Female, n (%) n = 383 | Male, n (%) n = 267 | p† |
|---|---|---|---|---|---|---|
| Fluoxetine * | 313 (48.2) | 22.59 ± 9.99 | 5–60 | 179 (46.7) | 134 (50.2) | 0.386 |
| Sertraline * | 222 (34.2) | 67.07 ± 32.98 | 25–200 | 145 (37.9) | 77 (28.8) | 0.017 |
| Mirtazapine | 44 (6.8) | 19.77 ± 10.62 | 7.5–45 | 17 (4.4) | 27 (10.1) | 0.005 |
| Escitalopram * | 41 (6.3) | 12.68 ± 7.01 | 2.5–40 | 32 (8.4) | 9 (3.4) | 0.010 |
| Imipramine | 21 (3.2) | 25.60 ± 6.22 | 12.5–50 | 11 (2.9) | 10 (3.7) | 0.536 |
| Paroxetine * | 16 (2.5) | 28.12 ± 15.59 | 10–60 | 5 (1.3) | 11 (4.1) | 0.023 |
| Citalopram * | 7 (1.1) | 21.43 ± 3.78 | 20–30 | 2 (0.5) | 5 (1.9) | 0.130 |
| Venlafaxine | 6 (0.9) | 187.50 ± 91.86 | 75–300 | 4 (1.0) | 2 (0.7) | 1.000 |
| Duloxetine | 3 (0.5) | 50.00 ± 17.32 | 30–60 | 3 (0.8) | 0 (0.0) | 0.273 |
| Fluvoxamine * | 2 (0.3) | 150.00 ± 70.71 | 100–200 | 0 (0.0) | 2 (0.7) | 0.168 |
| Trazodone | 1 (0.2) | 50.00 | – | 0 (0.0) | 1 (0.4) | 0.411 |
| Any SSRI | 601 (92.5) | 363 (94.8) | 238 (89.1) | 0.007 |
*SSRI. In total, 676 antidepressant prescriptions were recorded for 650 patients because 27 patients received two antidepressants concurrently; therefore, the column totals exceed the number of patients. †Pearson chi-square test, or Fisher’s exact test when an expected cell count was < 5. SD, standard deviation; SSRI, selective serotonin reuptake inhibitor.